Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000422963 | SCV000516120 | uncertain significance | not provided | 2024-06-24 | criteria provided, single submitter | clinical testing | Identified in a patient who met Task Force criteria for ARVC who also harbors a pathogenic variant in the PLN gene (PMID: 30763825); A published functional study suggests p.(A56T) may play a role in Plakoglobin, SAP97, and GSK3B distribution observed in intercalated disks (PMID: 30763825); Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30763825) |
Labcorp Genetics |
RCV000537218 | SCV000636281 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402135 | SCV002708501 | likely benign | Cardiovascular phenotype | 2024-04-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001828405 | SCV002084675 | uncertain significance | Emery-Dreifuss muscular dystrophy | 2021-09-08 | no assertion criteria provided | clinical testing |